Study of XJH05 ointment for mild-to-moderate plaque psoriasis
Treatments studied
Part of Skin clinical trials.
This trial tests a new ointment (XJH05) for people with mild-to-moderate plaque psoriasis. It aims to see if this treatment helps reduce symptoms and is safe for topical use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have plaque psoriasis (the most common type with thick, scaly patches).
- Your psoriasis should be mild to moderate, covering up to 10% of your body surface area (roughly the size of your palms).
- You must not have other forms of psoriasis, such as erythrodermic, pustular, or generalized guttate psoriasis.
- You must not have used systemic (pills or injections) psoriasis treatments, biologics, or topical steroids/retinoids recently (within the washout period).
- You must not have an active skin infection at the treatment area or be allergic to the study ointment or its ingredients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This study tests a new topical medicine, GM-XAN003, for mild to moderate plaque psoriasis. It aims to see if it is safe and helps clear skin patches.
This trial tests a new medication called HSK44459 for people with moderate to severe plaque psoriasis who need systemic therapy (medicine that works throughout the body). The goal is to see if it is safe and effective.
This study tests an investigational oral medication called HS-10374 for moderate to severe plaque psoriasis. It aims to see how well it clears skin and prevents flares compared to a placebo, and if it is safe for long-term use.
This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.
This trial tests an oral medication called HS-10374 for people with mild to moderate plaque psoriasis who haven't gotten enough relief from topical treatments. The study will check if the drug is safe and effective at clearing psoriasis patches.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.